Related Experiment Video
Updated: Mar 21, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Crystal structures of apo and inhibitor-bound TGFβR2 kinase domain: insights into TGFβR isoform selectivity
Andrew J Tebben1, Maxim Ruzanov1, Mian Gao2
1Molecular Structure and Design, Bristol-Myers Squibb R & D, PO Box 4000, Princeton, NJ 08543-4000, USA.
Abstract:
The cytokine TGF-β modulates a number of cellular activities and plays a critical role in development, hemostasis and physiology, as well as in diseases including cancer and fibrosis. TGF-β signals through two transmembrane serine/threonine kinase receptors: TGFβR1 and TGFβR2. Multiple structures of the TGFβR1 kinase domain are known, but the structure of TGFβR2 remains unreported. Wild-type TGFβR2 kinase domain was refractory to crystallization, leading to the design of two mutated constructs: firstly, a TGFβR1 chimeric protein with seven ATP-site residues mutated to their counterparts in TGFβR2, and secondly, a reduction of surface entropy through mutation of six charged residues on the surface of the TGFβR2 kinase domain to alanines. These yielded apo and inhibitor-bound crystals that diffracted to high resolution (<2 Å). Comparison of these structures with those of TGFβR1 reveal shared ligand contacts as well as differences in the ATP-binding sites, suggesting strategies for the design of pan and selective TGFβR inhibitors.
Insights
Researchers determined the structure of the Transforming Growth Factor-beta Receptor 2 (TGFβR2) kinase domain. This breakthrough enables the development of new TGF-beta inhibitors for treating diseases like cancer and fibrosis.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Transforming Growth Factor-beta (TGF-β) is a crucial cytokine regulating cellular activities in development, physiology, and diseases such as cancer and fibrosis.
- TGF-β signaling involves two transmembrane serine/threonine kinase receptors: TGFβR1 and TGFβR2.
- While TGFβR1 kinase domain structures are known, TGFβR2 kinase domain structure remained elusive.
Purpose of the Study:
- To determine the high-resolution crystal structure of the TGFβR2 kinase domain.
- To provide insights into TGF-β receptor structure for targeted inhibitor design.
Main Methods:
- Engineered two mutated constructs of the TGFβR2 kinase domain to overcome crystallization challenges.
- Utilized X-ray crystallography to obtain apo and inhibitor-bound crystals diffracting to high resolution (<2 Å).
Main Results:
- Successfully determined the crystal structure of the TGFβR2 kinase domain.
- Compared TGFβR2 structures with TGFβR1, identifying shared ligand contacts and distinct ATP-binding site features.
Conclusions:
- The determined TGFβR2 kinase domain structure provides a basis for understanding TGF-β signaling.
- Structural insights facilitate the design of novel pan and selective TGFβR inhibitors for therapeutic applications.
More Related Videos
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
TGF - β Signaling Pathway
Receptor Tyrosine Kinases
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Activation and Inactivation of G Proteins
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade